We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+11.75%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$65.7B
AUM Growth
+$6.62B
Cap. Flow
+$648M
Cap. Flow %
0.99%
Top 10 Hldgs %
27.2%
Holding
2,939
New
828
Increased
695
Reduced
744
Closed
553

Top Sells

Rank Stock Value
1
WMT icon
Walmart Inc
WMT
+$400M
2
STZ icon
Constellation Brands
STZ
+$345M
3
META icon
Meta Platforms (Facebook)
META
+$286M
4
KVUE icon
Kenvue
KVUE
+$277M
5
ABBV icon
AbbVie
ABBV
+$258M

Sector Composition

Rank Sector Weight
1 Technology 16.4%
2 Healthcare 13.22%
3 Consumer Discretionary 12.71%
4 Financials 7.66%
5 Communication Services 7.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PYCR
1876
DELISTED
Paycor HCM, Inc. Common Stock
PYCR
$540K ﹤0.01%
+27,791
New +$556K
QUIK icon
1877
QuickLogic
QUIK
$217M
$540K ﹤0.01%
+33,671
New +$485K
BATL icon
1878
Battalion Oil
BATL
$28.2M
$537K ﹤0.01%
94,800
+65,200
+220% +$454K
CREVW
1879
CALL
DELISTED
Carbon Revolution PLC Warrant
CREVW
$535K ﹤0.01%
50,576
LLY icon
1880
CALL
Eli Lilly
LLY
$1.09T
$535K ﹤0.01%
700
-200
-22% -$142K
FTQI icon
1881
First Trust Exchange-Traded Fund VI First Trust Hedged BuyWrite Income ETF
FTQI
$914M
$528K ﹤0.01%
+25,699
New +$519K
SAIA icon
1882
Saia
SAIA
$10.9B
$527K ﹤0.01%
+900
New +$471K
NGVC icon
1883
Vitamin Cottage Natural Grocers
NGVC
$744M
$525K ﹤0.01%
29,099
-219
-0.7% -$3.52K
NUVL
1884
DELISTED
Nuvalent
NUVL
$515K ﹤0.01%
6,852
-248
-3% -$19.7K
ATI icon
1885
ATI
ATI
$25.5B
$514K ﹤0.01%
+10,041
New +$454K
MD icon
1886
Pediatrix Medical
MD
$2.21B
$513K ﹤0.01%
+51,109
New +$476K
AGR
1887
DELISTED
Avangrid, Inc.
AGR
$511K ﹤0.01%
14,029
-141,400
-91% -$4.62M
ENGNW icon
1888
CALL
enGene Therapeutics Warrants
ENGNW
$509K ﹤0.01%
35,737
-26,403
-42% -$80.4K
YMM icon
1889
Full Truck Alliance
YMM
$9.64B
$507K ﹤0.01%
+69,700
New +$465K
POWW icon
1890
Outdoor Holding Co
POWW
$256M
$506K ﹤0.01%
184,100
WGS icon
1891
GeneDx Holdings
WGS
$1.84B
$505K ﹤0.01%
+55,318
New +$332K
FSTR icon
1892
Foster
FSTR
$439M
$504K ﹤0.01%
+18,460
New +$436K
TZOO icon
1893
Travelzoo
TZOO
$77.8M
$504K ﹤0.01%
49,516
-111,298
-69% -$1.03M
ARRY icon
1894
Array Technologies
ARRY
$785M
$504K ﹤0.01%
33,802
+2,702
+9% +$37.3K
HAIN icon
1895
Hain Celestial
HAIN
$44.8M
$501K ﹤0.01%
63,748
-118,634
-65% -$1.17M
ASTL icon
1896
Algoma Steel
ASTL
$463M
$499K ﹤0.01%
58,801
+2,350
+4% +$19.9K
J icon
1897
Jacobs Solutions
J
$16.6B
$498K ﹤0.01%
3,916
-17,460
-82% -$2.05M
TV icon
1898
Televisa
TV
$1.47B
$498K ﹤0.01%
155,537
-121,155
-44% -$367K
KWEB icon
1899
KraneShares CSI China Internet ETF
KWEB
$5.41B
$496K ﹤0.01%
18,900
-86,327
-82% -$2.18M
AM icon
1900
Antero Midstream
AM
$10.3B
$494K ﹤0.01%
+35,120
New +$449K

Similar funds

Marshall Wace's Q1 2024 Portfolio in Review

As of Q1 2024, Marshall Wace held 2,939 positions worth $65.7B, up 11% from $59B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Marshall Wace's Q1 2024 filing shows 828 new, 695 increased, 744 reduced and 553 closed positions. Its largest new stake was Vanguard S&P 500 ETF: 900,000 shares worth $433M. The largest sale was Walmart Inc, an estimated $400M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Marshall Wace's largest Q1 2024 buy was Vanguard S&P 500 ETF: 900,000 shares worth $433M.
  • Marshall Wace added most to Goldman Sachs in Q1 2024, an estimated $374M increase.
  • Marshall Wace's biggest Q1 2024 reduction was Walmart Inc, cutting an estimated $400M.
  • Marshall Wace fully exited Celsius Holdings in Q1 2024, selling an estimated $143M.
  • Marshall Wace's ten largest holdings make up 27% of its $65.7B portfolio in Q1 2024.
  • Marshall Wace opened 828 new positions and closed 553 in Q1 2024.
  • Marshall Wace's portfolio value rose 11% quarter-over-quarter to $65.7B.

Based on Marshall Wace's 13F filing for Q1 2024, filed 15 May 2024.